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Commentary
Implications for practice and research 
 Nurses must be aware that clinically depressed patients may exhibit 
reduced heart rate variability in response to stress
 Future research in this area needs to use larger sample sizes, and consider other
factors such as childhood trauma history, subjective stress ratings, sleep quality, and
co-morbidity with anxiety disorders. 
Context
Depression is the leading cause of disability and morbidity worldwide.1 A complex mix of bio-
psycho-social risk factors is thought to contribute to the development and maintenance of
depression.2 One of these factors is chronic mental stress.3  The review by Schiweck and
colleagues indicates that despite an increasing volume of research, there remains obscurity
around the effects of depression on stress reactivity.4  An increased understanding of this
may  have  important  contributions  for  future  remote  monitoring  and  individualized  care.
Therefore this review sought to explore and evaluate what the evidence base says about
Heart  Rate  (HR)  and  High  Frequency  Heart  Rate  Variation  (HF-HRV)  as  measurable
indicators for stress reactivity in clinically depressed patients.
Methods
The evidence based PRISMA guidelines  were used in  this systematic  review.5 Inclusion
criteria consisted of studies that used electrocardiography (ECG) testing in adults with major
depressive  disorders.   The studies identified had to report  on high frequency heart  rate
variability  or  respiratory  sinus  arrhythmia.   Furthermore,  studies  needed  to  include  the
identification of clinical depression. Studies that involved patients with schizophrenia, bipolar
disorder, eating disorders, autism, chronic fatigue syndrome or irritable bowel syndrome as
the predominant  diagnosis  were excluded.   There  is  no  clear  indication  of  whether  the
included papers were appraised for quality or not, however Schiweck and colleagues provide
information about the sample characteristics, data extraction and a comparison of the study
designs used by each paper. The authors highlight that heterogeneity in the included papers
made  it  impossible  to  undertake  a  meta-analysis;  hence,  they  justifiably  carried  out  a
qualitative synthesis of the findings.
Findings
Findings from the eleven included studies indicated that depressed patients had a different
HR and HF-HRV stress reactivity profile when compared to non-depressed patients. ECG
tests showed that depressed patients had blunted stress reactivity which was demonstrated
by a lower fluctuation in HR and HF-HRV. Interesting findings that require further empirical
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exploration included; blunted stress reactivity in depressed women that have a history of
childhood trauma, and gender differences in stress reactivity. Because reactions to stress
can be reliant on the type of stressor, future study designs should address the importance of
subjective reports of stress in relation to the task reaction. 
Commentary
This is a timely systematic review that purports to be the first to evaluate HR and HF-HRV
reactivity  to  specific  stress tasks.  The authors are transparent  about  the processes and
methods they employed and this  instils  confidence in  the internal  validity  of  the review.
Having two authors independently identify, assess eligibility and extract data in the selected
papers,  and enlisting  a  third  author  to  resolve  any disagreements  shows  an attempt  at
reducing selection bias. The authors acknowledge that the small number of studies in the
review may limit the extent to which the findings may be generalizable to a wider population
or to a wider range of stressors. They further note potential for publication bias which may
have resulted in the overrepresentation of studies with a positive outcome. That said, this
review is robust, and its findings make an important contribution to the body of knowledge on
heart rate as a measurable indicator for clinical depression. 
Evidence shows that a combination of a high resting heart rate and depressive symptoms
increases the risk of mortality.6 Schiweck and colleagues argue that there is value in also
measuring heart rate in response to stress as this can provide more information than resting
heart rate. This information might help to modify current practice and improve individualized
care. 
Key observations made in this  review relate to important  areas for  future research.  It  is
recommended  that  future  studies  should  explore  childhood  trauma  and  its  influences,
comorbid diagnoses of anxiety disorder and features of the population under investigation
(including medication use and how long the illness has been experienced).  These factors
have not  been explored  in  the studies  incorporated within  this  review by  Schiweck  and
colleagues.  Furthermore, research comprising of stress in real life situations could support
the development of additional approaches in clinical practice.
References
1. World  Health  Organization  (2018)  Depression.  https://www.who.int/news-room/fact-
sheets/detail/depression 
2. Garcia-Toro  M,  Aguirre  I.  Biopsychosocial  model  in  Depression  revisisted.  Medical
Hypotheses (2006) 68, 683-691.
3. Khan S, Khan RA Chronic Stress Leads to Anxiety and Depression. Annals of Psychiatry
and Mental Health (2017); 5(1): 1091
4. Schiweck C,  Piette D,  Berckmans D et  al.  Heart  rate and high frequency heart  rate
variability  during  stress  as  biomarker  for  clinical  depression.  A  systematic  review.
Psychol Med. 2018 Aug 23:1-12
2
5. Moher D, Liberati A, Tetzlaff J et al. Preferred reporting items for systematic reviews and
meta-analyses: the prisma statement. PLOS Medicine (2009); 6; e1000097
6. Nabi H, Kivimaki M, Empana JP et al. Combined effects of depressive symptoms and
resting heart rate on mortality: The Whitehall II Prospective Cohort Study.  Journal of
Clinical Psychiatry. 2011 Sep 72:9 1199-1206
Commentator Details: two commentators
Name: Lolita Alfred  Affiliation: University of Hull
Correspondence Address: Lecturer & Admissions Lead for Mental Health Nursing, Faculty
of Health Sciences 
University of Hull, Hull, HU6 7RX, UK
Email: L.Alfred@Hull.ac.uk
Name: Vickie Howard   Affiliation: University of Hull
Correspondence Address: Lecturer in Mental Health Nursing,
Faculty of Health Sciences
University of Hull, Hull, HU6 7RX, UK
Email: V.Howard@Hull.ac.uk
3
